On the stock market since 2007, it operates in the world of health and science. It has 23,500 employees. Now — the numbers.
This is an established company with proven profits.
Average growth of 9% a year over the last 4 years. Every year shown ended in profit.
The two sides balance each other out — the picture is neither a safety net nor an alarm.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Bets Against the Stock: The number of investors betting on a fall stands out.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
Over the last 3 years, sales grew about 11% a year on average.
It pays out $0.37 per share each year — regular cash for whoever holds the stock.
The weight of investors positioned for a fall can be felt in the market. Council score: 2/10.
On our five-subject report card, EXETF sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: EXETF is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.